Table 2.

Availability of infection-related health services substance abuse treatment programs by government and funding barrier^a

	Percent of substance treatment programs providing infection-related health services
Types of services	In the absence of perceived government barriers	In the presence of perceived government barriers	In the absence of perceived funding barriers	In the presence of perceived funding barriers
Patient education
HIV/AIDS	91	81	90	90
HCV	81	86	84	79
STI	82	88	83	81
Patient risk assessment
HIV/AIDS	90	92	91	90
HCV	80	64	81	76
STI	80	68	79	77
Patient counseling
HIV/AIDS	76	57	80	70
HCV	66	50	64	63
STI	68	52	71	66
Patient medical history and physical exam
HIV/AIDS	63	50	65	58
HCV	56	36b	60	48
STI	55	36	60	47b
Patient biological testing
HIV/AIDS	54	47	52	55
HCV	40	24	43	35
STI	47	30	42	48
Patient treatment
HIV/AIDS	44	42	43	44
HCV	33	27	36	31
STI	39	30	37	39
Patient monitoring
HIV/AIDS	49	50	40	54
HCV	38	42	38	39
STI	43	41	43	44

^aAs reported by state administrators. The sample size for responses to each survey question varied from 143 to 254. A sample size of 143 achieves 80% power to detect an effect size of 0.23 using a one degree of freedom Chi-Square test with a significance level of 0.05. An effect of 0.23 is the equivalent of at least a 0.12 difference (potentially larger depending on the values) in proportions between groups.

^bp<0.01 comparing treatment programs offering the service with programs that do not offer the service

HIV = human immunodeficiency virus

AIDS = acquired immunodeficiency syndrome

HCV = hepatitis C virus

STI = sexually transmitted infection